S Chen, M Triki, SP Carneiro,
OM Merkel - Nanoscale, 2025 - pubs.rsc.org
CRISPR-Cas9 has emerged as a highly effective and customizable genome editing tool,
holding significant promise for the treatment of KRAS mutations in lung cancer. In this study …